Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Addiction. 2017 Feb 28;112(6):1104–1111. doi: 10.1111/add.13772

Table 2.

Comparison of substance use and substance use frequency for participants with a lifetime history of insomnia, hypersomnia symptoms, or both insomnia and hypersomnia symptoms compared to no sleep disturbance symptoms assessed at pre-treatment.

β SE z/t p OR 95% C.I.
Insomnia symptoms
 Alcohol (reference: cocaine) 0.315 0.096 3.270 .001 1.37 [1.13, 1.66]
 Heroin (reference: cocaine) 0.282 0.082 3.430 .001 1.33 [1.13, 1.56]
 Alcohol (reference: heroin) 0.059 0.107 0.560 .579 1.06 [0.86, 1.31]
 Substance use frequency 0.424 0.071 5.940 <.001 - [0.28, 0.56]
Hypersomnia symptoms
 Alcohol (reference: cocaine) 0.068 0.130 0.530 .599 1.07 [0.83, 1.38]
 Cocaine (Reference: heroin) 0.370 0.128 2.900 .004 1.45 [1.13, 1.86]
 Alcohol (reference: heroin) 0.369 0.162 2.270 .023 1.45 [1.05, 1.99]
 Substance use frequency 0.050 0.098 0.510 .609 - [−0.14, 0.24]
Insomnia and hypersomnia symptoms
 Alcohol (reference: cocaine) 0.117 0.099 1.180 .238 1.12 [0.93, 1.37]
 Heroin (reference: cocaine) −0.007 0.088 −0.080 .934 0.99 [0.84, 1.18]
 Alcohol (reference: heroin) 0.096 0.113 0.850 .398 1.10 [0.88, 1.37]
 Substance use frequency 0.508 0.074 6.900 <.001 - [0.36, 0.65]

Dependent variables: alcohol use, cocaine use, heroin use, or substance use frequency assessed at pre-treatment. Independent variables: a lifetime history of insomnia, hypersomnia symptoms, or both insomnia and hypersomnia symptoms compared to no sleep disturbance symptoms assessed at pre-treatment. Covariates: age, sex, race, education level, and depression history assessed at pre-treatment.